VIVUS reacquires STENDRA(R) (Avanafil) commercial rights from Sanofi
VIVUS announced that it reached an agreement with Sanofi to return the commercial rights for STENDRA in Africa, the Middle East, Turkey and the Commonwealth of Independent States, including Russia, to VIVUS. March 27, 2017